Global In-Vitro Diagnostics Market Analysis and Forecast 2024-2030
Summary
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report? we counted In-Vitro Diagnostics reagent.
According to APO Research, The global In-Vitro Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of In-Vitro Diagnostics include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD and JNJ, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for In-Vitro Diagnostics, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of In-Vitro Diagnostics, also provides the revenue of main regions and countries. Of the upcoming market potential for In-Vitro Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the In-Vitro Diagnostics revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global In-Vitro Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for In-Vitro Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
In-Vitro Diagnostics segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of In-Vitro Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of In-Vitro Diagnostics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In-Vitro Diagnostics revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report? we counted In-Vitro Diagnostics reagent.
According to APO Research, The global In-Vitro Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of In-Vitro Diagnostics include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD and JNJ, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for In-Vitro Diagnostics, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of In-Vitro Diagnostics, also provides the revenue of main regions and countries. Of the upcoming market potential for In-Vitro Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the In-Vitro Diagnostics revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global In-Vitro Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for In-Vitro Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
In-Vitro Diagnostics segment by Company
- Roche
- Siemens
- Abbott
- Danaher
- Thermo Fisher
- BioMerieux
- Bio-Rad
- BD
- JNJ
- Sysmex
- KHB
- DaAn Gene
- Leadman
- BioSino
- BSBE
- Maccura
- Tissue Diagnostics
- Professional Diagnostic
- Molecular Diagnostic
- Diabetes Monitoring
- Other
- Diabetes
- Infectious Diseases
- Oncology
- Cardiology
- HIV
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of In-Vitro Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of In-Vitro Diagnostics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In-Vitro Diagnostics revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 In-Vitro Diagnostics Market by Type
1.2.1 Global In-Vitro Diagnostics Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Tissue Diagnostics
1.2.3 Professional Diagnostic
1.2.4 Molecular Diagnostic
1.2.5 Diabetes Monitoring
1.2.6 Other
1.3 In-Vitro Diagnostics Market by Application
1.3.1 Global In-Vitro Diagnostics Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Oncology
1.3.5 Cardiology
1.3.6 HIV
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 IN-VITRO DIAGNOSTICS MARKET DYNAMICS
2.1 In-Vitro Diagnostics Industry Trends
2.2 In-Vitro Diagnostics Industry Drivers
2.3 In-Vitro Diagnostics Industry Opportunities and Challenges
2.4 In-Vitro Diagnostics Industry Restraints
3 GLOBAL GROWTH PERSPECTIVE
3.1 Global In-Vitro Diagnostics Market Perspective (2019-2030)
3.2 Global In-Vitro Diagnostics Growth Trends by Region
3.2.1 Global In-Vitro Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global In-Vitro Diagnostics Market Size by Region (2019-2024)
3.2.3 Global In-Vitro Diagnostics Market Size by Region (2025-2030)
4 COMPETITIVE LANDSCAPE BY PLAYERS
4.1 Global In-Vitro Diagnostics Revenue by Players
4.1.1 Global In-Vitro Diagnostics Revenue by Players (2019-2024)
4.1.2 Global In-Vitro Diagnostics Revenue Market Share by Players (2019-2024)
4.1.3 Global In-Vitro Diagnostics Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global In-Vitro Diagnostics Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global In-Vitro Diagnostics Key Players Headquarters & Area Served
4.4 Global In-Vitro Diagnostics Players, Product Type & Application
4.5 Global In-Vitro Diagnostics Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global In-Vitro Diagnostics Market CR5 and HHI
4.6.2 Global Top 5 and 10 In-Vitro Diagnostics Players Market Share by Revenue in 2023
4.6.3 2023 In-Vitro Diagnostics Tier 1, Tier 2, and Tier
5 IN-VITRO DIAGNOSTICS MARKET SIZE BY TYPE
5.1 Global In-Vitro Diagnostics Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global In-Vitro Diagnostics Revenue by Type (2019-2030)
5.3 Global In-Vitro Diagnostics Revenue Market Share by Type (2019-2030)
6 IN-VITRO DIAGNOSTICS MARKET SIZE BY APPLICATION
6.1 Global In-Vitro Diagnostics Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global In-Vitro Diagnostics Revenue by Application (2019-2030)
6.3 Global In-Vitro Diagnostics Revenue Market Share by Application (2019-2030)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Comapny Information
7.1.2 Roche Business Overview
7.1.3 Roche In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.1.4 Roche In-Vitro Diagnostics Product Portfolio
7.1.5 Roche Recent Developments
7.2 Siemens
7.2.1 Siemens Comapny Information
7.2.2 Siemens Business Overview
7.2.3 Siemens In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.2.4 Siemens In-Vitro Diagnostics Product Portfolio
7.2.5 Siemens Recent Developments
7.3 Abbott
7.3.1 Abbott Comapny Information
7.3.2 Abbott Business Overview
7.3.3 Abbott In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.3.4 Abbott In-Vitro Diagnostics Product Portfolio
7.3.5 Abbott Recent Developments
7.4 Danaher
7.4.1 Danaher Comapny Information
7.4.2 Danaher Business Overview
7.4.3 Danaher In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.4.4 Danaher In-Vitro Diagnostics Product Portfolio
7.4.5 Danaher Recent Developments
7.5 Thermo Fisher
7.5.1 Thermo Fisher Comapny Information
7.5.2 Thermo Fisher Business Overview
7.5.3 Thermo Fisher In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.5.4 Thermo Fisher In-Vitro Diagnostics Product Portfolio
7.5.5 Thermo Fisher Recent Developments
7.6 BioMerieux
7.6.1 BioMerieux Comapny Information
7.6.2 BioMerieux Business Overview
7.6.3 BioMerieux In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.6.4 BioMerieux In-Vitro Diagnostics Product Portfolio
7.6.5 BioMerieux Recent Developments
7.7 Bio-Rad
7.7.1 Bio-Rad Comapny Information
7.7.2 Bio-Rad Business Overview
7.7.3 Bio-Rad In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.7.4 Bio-Rad In-Vitro Diagnostics Product Portfolio
7.7.5 Bio-Rad Recent Developments
7.8 BD
7.8.1 BD Comapny Information
7.8.2 BD Business Overview
7.8.3 BD In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.8.4 BD In-Vitro Diagnostics Product Portfolio
7.8.5 BD Recent Developments
7.9 JNJ
7.9.1 JNJ Comapny Information
7.9.2 JNJ Business Overview
7.9.3 JNJ In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.9.4 JNJ In-Vitro Diagnostics Product Portfolio
7.9.5 JNJ Recent Developments
7.10 Sysmex
7.10.1 Sysmex Comapny Information
7.10.2 Sysmex Business Overview
7.10.3 Sysmex In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.10.4 Sysmex In-Vitro Diagnostics Product Portfolio
7.10.5 Sysmex Recent Developments
7.11 KHB
7.11.1 KHB Comapny Information
7.11.2 KHB Business Overview
7.11.3 KHB In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.11.4 KHB In-Vitro Diagnostics Product Portfolio
7.11.5 KHB Recent Developments
7.12 DaAn Gene
7.12.1 DaAn Gene Comapny Information
7.12.2 DaAn Gene Business Overview
7.12.3 DaAn Gene In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.12.4 DaAn Gene In-Vitro Diagnostics Product Portfolio
7.12.5 DaAn Gene Recent Developments
7.13 Leadman
7.13.1 Leadman Comapny Information
7.13.2 Leadman Business Overview
7.13.3 Leadman In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.13.4 Leadman In-Vitro Diagnostics Product Portfolio
7.13.5 Leadman Recent Developments
7.14 BioSino
7.14.1 BioSino Comapny Information
7.14.2 BioSino Business Overview
7.14.3 BioSino In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.14.4 BioSino In-Vitro Diagnostics Product Portfolio
7.14.5 BioSino Recent Developments
7.15 BSBE
7.15.1 BSBE Comapny Information
7.15.2 BSBE Business Overview
7.15.3 BSBE In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.15.4 BSBE In-Vitro Diagnostics Product Portfolio
7.15.5 BSBE Recent Developments
7.16 Maccura
7.16.1 Maccura Comapny Information
7.16.2 Maccura Business Overview
7.16.3 Maccura In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.16.4 Maccura In-Vitro Diagnostics Product Portfolio
7.16.5 Maccura Recent Developments
8 NORTH AMERICA
8.1 North America In-Vitro Diagnostics Revenue (2019-2030)
8.2 North America In-Vitro Diagnostics Revenue by Type (2019-2030)
8.2.1 North America In-Vitro Diagnostics Revenue by Type (2019-2024)
8.2.2 North America In-Vitro Diagnostics Revenue by Type (2025-2030)
8.3 North America In-Vitro Diagnostics Revenue Share by Type (2019-2030)
8.4 North America In-Vitro Diagnostics Revenue by Application (2019-2030)
8.4.1 North America In-Vitro Diagnostics Revenue by Application (2019-2024)
8.4.2 North America In-Vitro Diagnostics Revenue by Application (2025-2030)
8.5 North America In-Vitro Diagnostics Revenue Share by Application (2019-2030)
8.6 North America In-Vitro Diagnostics Revenue by Country
8.6.1 North America In-Vitro Diagnostics Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America In-Vitro Diagnostics Revenue by Country (2019-2024)
8.6.3 North America In-Vitro Diagnostics Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 EUROPE
9.1 Europe In-Vitro Diagnostics Revenue (2019-2030)
9.2 Europe In-Vitro Diagnostics Revenue by Type (2019-2030)
9.2.1 Europe In-Vitro Diagnostics Revenue by Type (2019-2024)
9.2.2 Europe In-Vitro Diagnostics Revenue by Type (2025-2030)
9.3 Europe In-Vitro Diagnostics Revenue Share by Type (2019-2030)
9.4 Europe In-Vitro Diagnostics Revenue by Application (2019-2030)
9.4.1 Europe In-Vitro Diagnostics Revenue by Application (2019-2024)
9.4.2 Europe In-Vitro Diagnostics Revenue by Application (2025-2030)
9.5 Europe In-Vitro Diagnostics Revenue Share by Application (2019-2030)
9.6 Europe In-Vitro Diagnostics Revenue by Country
9.6.1 Europe In-Vitro Diagnostics Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe In-Vitro Diagnostics Revenue by Country (2019-2024)
9.6.3 Europe In-Vitro Diagnostics Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 CHINA
10.1 China In-Vitro Diagnostics Revenue (2019-2030)
10.2 China In-Vitro Diagnostics Revenue by Type (2019-2030)
10.2.1 China In-Vitro Diagnostics Revenue by Type (2019-2024)
10.2.2 China In-Vitro Diagnostics Revenue by Type (2025-2030)
10.3 China In-Vitro Diagnostics Revenue Share by Type (2019-2030)
10.4 China In-Vitro Diagnostics Revenue by Application (2019-2030)
10.4.1 China In-Vitro Diagnostics Revenue by Application (2019-2024)
10.4.2 China In-Vitro Diagnostics Revenue by Application (2025-2030)
10.5 China In-Vitro Diagnostics Revenue Share by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia In-Vitro Diagnostics Revenue (2019-2030)
11.2 Asia In-Vitro Diagnostics Revenue by Type (2019-2030)
11.2.1 Asia In-Vitro Diagnostics Revenue by Type (2019-2024)
11.2.2 Asia In-Vitro Diagnostics Revenue by Type (2025-2030)
11.3 Asia In-Vitro Diagnostics Revenue Share by Type (2019-2030)
11.4 Asia In-Vitro Diagnostics Revenue by Application (2019-2030)
11.4.1 Asia In-Vitro Diagnostics Revenue by Application (2019-2024)
11.4.2 Asia In-Vitro Diagnostics Revenue by Application (2025-2030)
11.5 Asia In-Vitro Diagnostics Revenue Share by Application (2019-2030)
11.6 Asia In-Vitro Diagnostics Revenue by Country
11.6.1 Asia In-Vitro Diagnostics Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia In-Vitro Diagnostics Revenue by Country (2019-2024)
11.6.3 Asia In-Vitro Diagnostics Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 MIDDLE EAST, AFRICA, LATIN AMERICA
12.1 MEALA In-Vitro Diagnostics Revenue (2019-2030)
12.2 MEALA In-Vitro Diagnostics Revenue by Type (2019-2030)
12.2.1 MEALA In-Vitro Diagnostics Revenue by Type (2019-2024)
12.2.2 MEALA In-Vitro Diagnostics Revenue by Type (2025-2030)
12.3 MEALA In-Vitro Diagnostics Revenue Share by Type (2019-2030)
12.4 MEALA In-Vitro Diagnostics Revenue by Application (2019-2030)
12.4.1 MEALA In-Vitro Diagnostics Revenue by Application (2019-2024)
12.4.2 MEALA In-Vitro Diagnostics Revenue by Application (2025-2030)
12.5 MEALA In-Vitro Diagnostics Revenue Share by Application (2019-2030)
12.6 MEALA In-Vitro Diagnostics Revenue by Country
12.6.1 MEALA In-Vitro Diagnostics Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA In-Vitro Diagnostics Revenue by Country (2019-2024)
12.6.3 MEALA In-Vitro Diagnostics Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 In-Vitro Diagnostics Market by Type
1.2.1 Global In-Vitro Diagnostics Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Tissue Diagnostics
1.2.3 Professional Diagnostic
1.2.4 Molecular Diagnostic
1.2.5 Diabetes Monitoring
1.2.6 Other
1.3 In-Vitro Diagnostics Market by Application
1.3.1 Global In-Vitro Diagnostics Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Oncology
1.3.5 Cardiology
1.3.6 HIV
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 IN-VITRO DIAGNOSTICS MARKET DYNAMICS
2.1 In-Vitro Diagnostics Industry Trends
2.2 In-Vitro Diagnostics Industry Drivers
2.3 In-Vitro Diagnostics Industry Opportunities and Challenges
2.4 In-Vitro Diagnostics Industry Restraints
3 GLOBAL GROWTH PERSPECTIVE
3.1 Global In-Vitro Diagnostics Market Perspective (2019-2030)
3.2 Global In-Vitro Diagnostics Growth Trends by Region
3.2.1 Global In-Vitro Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global In-Vitro Diagnostics Market Size by Region (2019-2024)
3.2.3 Global In-Vitro Diagnostics Market Size by Region (2025-2030)
4 COMPETITIVE LANDSCAPE BY PLAYERS
4.1 Global In-Vitro Diagnostics Revenue by Players
4.1.1 Global In-Vitro Diagnostics Revenue by Players (2019-2024)
4.1.2 Global In-Vitro Diagnostics Revenue Market Share by Players (2019-2024)
4.1.3 Global In-Vitro Diagnostics Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global In-Vitro Diagnostics Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global In-Vitro Diagnostics Key Players Headquarters & Area Served
4.4 Global In-Vitro Diagnostics Players, Product Type & Application
4.5 Global In-Vitro Diagnostics Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global In-Vitro Diagnostics Market CR5 and HHI
4.6.2 Global Top 5 and 10 In-Vitro Diagnostics Players Market Share by Revenue in 2023
4.6.3 2023 In-Vitro Diagnostics Tier 1, Tier 2, and Tier
5 IN-VITRO DIAGNOSTICS MARKET SIZE BY TYPE
5.1 Global In-Vitro Diagnostics Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global In-Vitro Diagnostics Revenue by Type (2019-2030)
5.3 Global In-Vitro Diagnostics Revenue Market Share by Type (2019-2030)
6 IN-VITRO DIAGNOSTICS MARKET SIZE BY APPLICATION
6.1 Global In-Vitro Diagnostics Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global In-Vitro Diagnostics Revenue by Application (2019-2030)
6.3 Global In-Vitro Diagnostics Revenue Market Share by Application (2019-2030)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Comapny Information
7.1.2 Roche Business Overview
7.1.3 Roche In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.1.4 Roche In-Vitro Diagnostics Product Portfolio
7.1.5 Roche Recent Developments
7.2 Siemens
7.2.1 Siemens Comapny Information
7.2.2 Siemens Business Overview
7.2.3 Siemens In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.2.4 Siemens In-Vitro Diagnostics Product Portfolio
7.2.5 Siemens Recent Developments
7.3 Abbott
7.3.1 Abbott Comapny Information
7.3.2 Abbott Business Overview
7.3.3 Abbott In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.3.4 Abbott In-Vitro Diagnostics Product Portfolio
7.3.5 Abbott Recent Developments
7.4 Danaher
7.4.1 Danaher Comapny Information
7.4.2 Danaher Business Overview
7.4.3 Danaher In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.4.4 Danaher In-Vitro Diagnostics Product Portfolio
7.4.5 Danaher Recent Developments
7.5 Thermo Fisher
7.5.1 Thermo Fisher Comapny Information
7.5.2 Thermo Fisher Business Overview
7.5.3 Thermo Fisher In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.5.4 Thermo Fisher In-Vitro Diagnostics Product Portfolio
7.5.5 Thermo Fisher Recent Developments
7.6 BioMerieux
7.6.1 BioMerieux Comapny Information
7.6.2 BioMerieux Business Overview
7.6.3 BioMerieux In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.6.4 BioMerieux In-Vitro Diagnostics Product Portfolio
7.6.5 BioMerieux Recent Developments
7.7 Bio-Rad
7.7.1 Bio-Rad Comapny Information
7.7.2 Bio-Rad Business Overview
7.7.3 Bio-Rad In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.7.4 Bio-Rad In-Vitro Diagnostics Product Portfolio
7.7.5 Bio-Rad Recent Developments
7.8 BD
7.8.1 BD Comapny Information
7.8.2 BD Business Overview
7.8.3 BD In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.8.4 BD In-Vitro Diagnostics Product Portfolio
7.8.5 BD Recent Developments
7.9 JNJ
7.9.1 JNJ Comapny Information
7.9.2 JNJ Business Overview
7.9.3 JNJ In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.9.4 JNJ In-Vitro Diagnostics Product Portfolio
7.9.5 JNJ Recent Developments
7.10 Sysmex
7.10.1 Sysmex Comapny Information
7.10.2 Sysmex Business Overview
7.10.3 Sysmex In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.10.4 Sysmex In-Vitro Diagnostics Product Portfolio
7.10.5 Sysmex Recent Developments
7.11 KHB
7.11.1 KHB Comapny Information
7.11.2 KHB Business Overview
7.11.3 KHB In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.11.4 KHB In-Vitro Diagnostics Product Portfolio
7.11.5 KHB Recent Developments
7.12 DaAn Gene
7.12.1 DaAn Gene Comapny Information
7.12.2 DaAn Gene Business Overview
7.12.3 DaAn Gene In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.12.4 DaAn Gene In-Vitro Diagnostics Product Portfolio
7.12.5 DaAn Gene Recent Developments
7.13 Leadman
7.13.1 Leadman Comapny Information
7.13.2 Leadman Business Overview
7.13.3 Leadman In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.13.4 Leadman In-Vitro Diagnostics Product Portfolio
7.13.5 Leadman Recent Developments
7.14 BioSino
7.14.1 BioSino Comapny Information
7.14.2 BioSino Business Overview
7.14.3 BioSino In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.14.4 BioSino In-Vitro Diagnostics Product Portfolio
7.14.5 BioSino Recent Developments
7.15 BSBE
7.15.1 BSBE Comapny Information
7.15.2 BSBE Business Overview
7.15.3 BSBE In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.15.4 BSBE In-Vitro Diagnostics Product Portfolio
7.15.5 BSBE Recent Developments
7.16 Maccura
7.16.1 Maccura Comapny Information
7.16.2 Maccura Business Overview
7.16.3 Maccura In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
7.16.4 Maccura In-Vitro Diagnostics Product Portfolio
7.16.5 Maccura Recent Developments
8 NORTH AMERICA
8.1 North America In-Vitro Diagnostics Revenue (2019-2030)
8.2 North America In-Vitro Diagnostics Revenue by Type (2019-2030)
8.2.1 North America In-Vitro Diagnostics Revenue by Type (2019-2024)
8.2.2 North America In-Vitro Diagnostics Revenue by Type (2025-2030)
8.3 North America In-Vitro Diagnostics Revenue Share by Type (2019-2030)
8.4 North America In-Vitro Diagnostics Revenue by Application (2019-2030)
8.4.1 North America In-Vitro Diagnostics Revenue by Application (2019-2024)
8.4.2 North America In-Vitro Diagnostics Revenue by Application (2025-2030)
8.5 North America In-Vitro Diagnostics Revenue Share by Application (2019-2030)
8.6 North America In-Vitro Diagnostics Revenue by Country
8.6.1 North America In-Vitro Diagnostics Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America In-Vitro Diagnostics Revenue by Country (2019-2024)
8.6.3 North America In-Vitro Diagnostics Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 EUROPE
9.1 Europe In-Vitro Diagnostics Revenue (2019-2030)
9.2 Europe In-Vitro Diagnostics Revenue by Type (2019-2030)
9.2.1 Europe In-Vitro Diagnostics Revenue by Type (2019-2024)
9.2.2 Europe In-Vitro Diagnostics Revenue by Type (2025-2030)
9.3 Europe In-Vitro Diagnostics Revenue Share by Type (2019-2030)
9.4 Europe In-Vitro Diagnostics Revenue by Application (2019-2030)
9.4.1 Europe In-Vitro Diagnostics Revenue by Application (2019-2024)
9.4.2 Europe In-Vitro Diagnostics Revenue by Application (2025-2030)
9.5 Europe In-Vitro Diagnostics Revenue Share by Application (2019-2030)
9.6 Europe In-Vitro Diagnostics Revenue by Country
9.6.1 Europe In-Vitro Diagnostics Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe In-Vitro Diagnostics Revenue by Country (2019-2024)
9.6.3 Europe In-Vitro Diagnostics Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 CHINA
10.1 China In-Vitro Diagnostics Revenue (2019-2030)
10.2 China In-Vitro Diagnostics Revenue by Type (2019-2030)
10.2.1 China In-Vitro Diagnostics Revenue by Type (2019-2024)
10.2.2 China In-Vitro Diagnostics Revenue by Type (2025-2030)
10.3 China In-Vitro Diagnostics Revenue Share by Type (2019-2030)
10.4 China In-Vitro Diagnostics Revenue by Application (2019-2030)
10.4.1 China In-Vitro Diagnostics Revenue by Application (2019-2024)
10.4.2 China In-Vitro Diagnostics Revenue by Application (2025-2030)
10.5 China In-Vitro Diagnostics Revenue Share by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia In-Vitro Diagnostics Revenue (2019-2030)
11.2 Asia In-Vitro Diagnostics Revenue by Type (2019-2030)
11.2.1 Asia In-Vitro Diagnostics Revenue by Type (2019-2024)
11.2.2 Asia In-Vitro Diagnostics Revenue by Type (2025-2030)
11.3 Asia In-Vitro Diagnostics Revenue Share by Type (2019-2030)
11.4 Asia In-Vitro Diagnostics Revenue by Application (2019-2030)
11.4.1 Asia In-Vitro Diagnostics Revenue by Application (2019-2024)
11.4.2 Asia In-Vitro Diagnostics Revenue by Application (2025-2030)
11.5 Asia In-Vitro Diagnostics Revenue Share by Application (2019-2030)
11.6 Asia In-Vitro Diagnostics Revenue by Country
11.6.1 Asia In-Vitro Diagnostics Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia In-Vitro Diagnostics Revenue by Country (2019-2024)
11.6.3 Asia In-Vitro Diagnostics Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 MIDDLE EAST, AFRICA, LATIN AMERICA
12.1 MEALA In-Vitro Diagnostics Revenue (2019-2030)
12.2 MEALA In-Vitro Diagnostics Revenue by Type (2019-2030)
12.2.1 MEALA In-Vitro Diagnostics Revenue by Type (2019-2024)
12.2.2 MEALA In-Vitro Diagnostics Revenue by Type (2025-2030)
12.3 MEALA In-Vitro Diagnostics Revenue Share by Type (2019-2030)
12.4 MEALA In-Vitro Diagnostics Revenue by Application (2019-2030)
12.4.1 MEALA In-Vitro Diagnostics Revenue by Application (2019-2024)
12.4.2 MEALA In-Vitro Diagnostics Revenue by Application (2025-2030)
12.5 MEALA In-Vitro Diagnostics Revenue Share by Application (2019-2030)
12.6 MEALA In-Vitro Diagnostics Revenue by Country
12.6.1 MEALA In-Vitro Diagnostics Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA In-Vitro Diagnostics Revenue by Country (2019-2024)
12.6.3 MEALA In-Vitro Diagnostics Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Global In-Vitro Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Tissue Diagnostics Major Manufacturers
Table 2. Professional Diagnostic Major Manufacturers
Table 3. Molecular Diagnostic Major Manufacturers
Table 4. Diabetes Monitoring Major Manufacturers
Table 5. Other Major Manufacturers
Table 6. Global In-Vitro Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Diabetes Major Manufacturers
Table 8. Infectious Diseases Major Manufacturers
Table 9. Oncology Major Manufacturers
Table 10. Cardiology Major Manufacturers
Table 11. HIV Major Manufacturers
Table 12. Other Major Manufacturers
Table 13. In-Vitro Diagnostics Industry Trends
Table 14. In-Vitro Diagnostics Industry Drivers
Table 15. In-Vitro Diagnostics Industry Opportunities and Challenges
Table 16. In-Vitro Diagnostics Industry Restraints
Table 17. Global In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 18. Global In-Vitro Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 19. Global In-Vitro Diagnostics Market Share by Region (2019-2024)
Table 20. Global In-Vitro Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 21. Global In-Vitro Diagnostics Market Share by Region (2025-2030)
Table 22. Global In-Vitro Diagnostics Revenue by Players (US$ Million) & (2019-2024)
Table 23. Global In-Vitro Diagnostics Revenue Market Share by Players (2019-2024)
Table 24. Global In-Vitro Diagnostics Key Players Ranking, 2022 VS 2023 VS 2024
Table 25. Global In-Vitro Diagnostics Key Players Headquarters & Area Served
Table 26. Global In-Vitro Diagnostics Players, Product Type & Application
Table 27. Global In-Vitro Diagnostics Players Commercialization Time
Table 28. Global Players Market Concentration Ratio (CR5 and HHI)
Table 29. Global In-Vitro Diagnostics by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 30. Global In-Vitro Diagnostics Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Global In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global In-Vitro Diagnostics Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 34. Global In-Vitro Diagnostics Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 35. Global In-Vitro Diagnostics Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Global In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 37. Global In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Table 38. Global In-Vitro Diagnostics Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 39. Global In-Vitro Diagnostics Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 40. Roche Company Information
Table 41. Roche Business Overview
Table 42. Roche In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 43. Roche In-Vitro Diagnostics Product Portfolio
Table 44. Roche Recent Development
Table 45. Siemens Company Information
Table 46. Siemens Business Overview
Table 47. Siemens In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 48. Siemens In-Vitro Diagnostics Product Portfolio
Table 49. Siemens Recent Development
Table 50. Abbott Company Information
Table 51. Abbott Business Overview
Table 52. Abbott In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 53. Abbott In-Vitro Diagnostics Product Portfolio
Table 54. Abbott Recent Development
Table 55. Danaher Company Information
Table 56. Danaher Business Overview
Table 57. Danaher In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 58. Danaher In-Vitro Diagnostics Product Portfolio
Table 59. Danaher Recent Development
Table 60. Thermo Fisher Company Information
Table 61. Thermo Fisher Business Overview
Table 62. Thermo Fisher In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 63. Thermo Fisher In-Vitro Diagnostics Product Portfolio
Table 64. Thermo Fisher Recent Development
Table 65. BioMerieux Company Information
Table 66. BioMerieux Business Overview
Table 67. BioMerieux In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 68. BioMerieux In-Vitro Diagnostics Product Portfolio
Table 69. BioMerieux Recent Development
Table 70. Bio-Rad Company Information
Table 71. Bio-Rad Business Overview
Table 72. Bio-Rad In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 73. Bio-Rad In-Vitro Diagnostics Product Portfolio
Table 74. Bio-Rad Recent Development
Table 75. BD Company Information
Table 76. BD Business Overview
Table 77. BD In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 78. BD In-Vitro Diagnostics Product Portfolio
Table 79. BD Recent Development
Table 80. JNJ Company Information
Table 81. JNJ Business Overview
Table 82. JNJ In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 83. JNJ In-Vitro Diagnostics Product Portfolio
Table 84. JNJ Recent Development
Table 85. Sysmex Company Information
Table 86. Sysmex Business Overview
Table 87. Sysmex In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 88. Sysmex In-Vitro Diagnostics Product Portfolio
Table 89. Sysmex Recent Development
Table 90. KHB Company Information
Table 91. KHB Business Overview
Table 92. KHB In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. KHB In-Vitro Diagnostics Product Portfolio
Table 94. KHB Recent Development
Table 95. DaAn Gene Company Information
Table 96. DaAn Gene Business Overview
Table 97. DaAn Gene In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. DaAn Gene In-Vitro Diagnostics Product Portfolio
Table 99. DaAn Gene Recent Development
Table 100. Leadman Company Information
Table 101. Leadman Business Overview
Table 102. Leadman In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Leadman In-Vitro Diagnostics Product Portfolio
Table 104. Leadman Recent Development
Table 105. BioSino Company Information
Table 106. BioSino Business Overview
Table 107. BioSino In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. BioSino In-Vitro Diagnostics Product Portfolio
Table 109. BioSino Recent Development
Table 110. BSBE Company Information
Table 111. BSBE Business Overview
Table 112. BSBE In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. BSBE In-Vitro Diagnostics Product Portfolio
Table 114. BSBE Recent Development
Table 115. Maccura Company Information
Table 116. Maccura Business Overview
Table 117. Maccura In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Maccura In-Vitro Diagnostics Product Portfolio
Table 119. Maccura Recent Development
Table 120. North America In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 121. North America In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 122. North America In-Vitro Diagnostics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 123. North America In-Vitro Diagnostics Revenue by Country (2019-2024) & (US$ Million)
Table 124. North America In-Vitro Diagnostics Revenue by Country (2025-2030) & (US$ Million)
Table 125. Europe In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 126. Europe In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 127. Europe In-Vitro Diagnostics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 128. Europe In-Vitro Diagnostics Revenue by Country (2019-2024) & (US$ Million)
Table 129. Europe In-Vitro Diagnostics Revenue by Country (2025-2030) & (US$ Million)
Table 130. China In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 131. China In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 132. Asia In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 133. Asia In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 134. Asia In-Vitro Diagnostics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 135. Asia In-Vitro Diagnostics Revenue by Country (2019-2024) & (US$ Million)
Table 136. Asia In-Vitro Diagnostics Revenue by Country (2025-2030) & (US$ Million)
Table 137. MEALA In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 138. MEALA In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 139. MEALA In-Vitro Diagnostics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 140. MEALA In-Vitro Diagnostics Revenue by Country (2019-2024) & (US$ Million)
Table 141. MEALA In-Vitro Diagnostics Revenue by Country (2025-2030) & (US$ Million)
Table 142. Research Programs/Design for This Report
Table 143. Authors List of This Report
Table 144. Secondary Sources
Table 145. Primary Sources
Table 1. Global In-Vitro Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Tissue Diagnostics Major Manufacturers
Table 2. Professional Diagnostic Major Manufacturers
Table 3. Molecular Diagnostic Major Manufacturers
Table 4. Diabetes Monitoring Major Manufacturers
Table 5. Other Major Manufacturers
Table 6. Global In-Vitro Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Diabetes Major Manufacturers
Table 8. Infectious Diseases Major Manufacturers
Table 9. Oncology Major Manufacturers
Table 10. Cardiology Major Manufacturers
Table 11. HIV Major Manufacturers
Table 12. Other Major Manufacturers
Table 13. In-Vitro Diagnostics Industry Trends
Table 14. In-Vitro Diagnostics Industry Drivers
Table 15. In-Vitro Diagnostics Industry Opportunities and Challenges
Table 16. In-Vitro Diagnostics Industry Restraints
Table 17. Global In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 18. Global In-Vitro Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 19. Global In-Vitro Diagnostics Market Share by Region (2019-2024)
Table 20. Global In-Vitro Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 21. Global In-Vitro Diagnostics Market Share by Region (2025-2030)
Table 22. Global In-Vitro Diagnostics Revenue by Players (US$ Million) & (2019-2024)
Table 23. Global In-Vitro Diagnostics Revenue Market Share by Players (2019-2024)
Table 24. Global In-Vitro Diagnostics Key Players Ranking, 2022 VS 2023 VS 2024
Table 25. Global In-Vitro Diagnostics Key Players Headquarters & Area Served
Table 26. Global In-Vitro Diagnostics Players, Product Type & Application
Table 27. Global In-Vitro Diagnostics Players Commercialization Time
Table 28. Global Players Market Concentration Ratio (CR5 and HHI)
Table 29. Global In-Vitro Diagnostics by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 30. Global In-Vitro Diagnostics Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Global In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global In-Vitro Diagnostics Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 34. Global In-Vitro Diagnostics Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 35. Global In-Vitro Diagnostics Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Global In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 37. Global In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Table 38. Global In-Vitro Diagnostics Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 39. Global In-Vitro Diagnostics Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 40. Roche Company Information
Table 41. Roche Business Overview
Table 42. Roche In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 43. Roche In-Vitro Diagnostics Product Portfolio
Table 44. Roche Recent Development
Table 45. Siemens Company Information
Table 46. Siemens Business Overview
Table 47. Siemens In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 48. Siemens In-Vitro Diagnostics Product Portfolio
Table 49. Siemens Recent Development
Table 50. Abbott Company Information
Table 51. Abbott Business Overview
Table 52. Abbott In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 53. Abbott In-Vitro Diagnostics Product Portfolio
Table 54. Abbott Recent Development
Table 55. Danaher Company Information
Table 56. Danaher Business Overview
Table 57. Danaher In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 58. Danaher In-Vitro Diagnostics Product Portfolio
Table 59. Danaher Recent Development
Table 60. Thermo Fisher Company Information
Table 61. Thermo Fisher Business Overview
Table 62. Thermo Fisher In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 63. Thermo Fisher In-Vitro Diagnostics Product Portfolio
Table 64. Thermo Fisher Recent Development
Table 65. BioMerieux Company Information
Table 66. BioMerieux Business Overview
Table 67. BioMerieux In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 68. BioMerieux In-Vitro Diagnostics Product Portfolio
Table 69. BioMerieux Recent Development
Table 70. Bio-Rad Company Information
Table 71. Bio-Rad Business Overview
Table 72. Bio-Rad In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 73. Bio-Rad In-Vitro Diagnostics Product Portfolio
Table 74. Bio-Rad Recent Development
Table 75. BD Company Information
Table 76. BD Business Overview
Table 77. BD In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 78. BD In-Vitro Diagnostics Product Portfolio
Table 79. BD Recent Development
Table 80. JNJ Company Information
Table 81. JNJ Business Overview
Table 82. JNJ In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 83. JNJ In-Vitro Diagnostics Product Portfolio
Table 84. JNJ Recent Development
Table 85. Sysmex Company Information
Table 86. Sysmex Business Overview
Table 87. Sysmex In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 88. Sysmex In-Vitro Diagnostics Product Portfolio
Table 89. Sysmex Recent Development
Table 90. KHB Company Information
Table 91. KHB Business Overview
Table 92. KHB In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. KHB In-Vitro Diagnostics Product Portfolio
Table 94. KHB Recent Development
Table 95. DaAn Gene Company Information
Table 96. DaAn Gene Business Overview
Table 97. DaAn Gene In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. DaAn Gene In-Vitro Diagnostics Product Portfolio
Table 99. DaAn Gene Recent Development
Table 100. Leadman Company Information
Table 101. Leadman Business Overview
Table 102. Leadman In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Leadman In-Vitro Diagnostics Product Portfolio
Table 104. Leadman Recent Development
Table 105. BioSino Company Information
Table 106. BioSino Business Overview
Table 107. BioSino In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. BioSino In-Vitro Diagnostics Product Portfolio
Table 109. BioSino Recent Development
Table 110. BSBE Company Information
Table 111. BSBE Business Overview
Table 112. BSBE In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. BSBE In-Vitro Diagnostics Product Portfolio
Table 114. BSBE Recent Development
Table 115. Maccura Company Information
Table 116. Maccura Business Overview
Table 117. Maccura In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Maccura In-Vitro Diagnostics Product Portfolio
Table 119. Maccura Recent Development
Table 120. North America In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 121. North America In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 122. North America In-Vitro Diagnostics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 123. North America In-Vitro Diagnostics Revenue by Country (2019-2024) & (US$ Million)
Table 124. North America In-Vitro Diagnostics Revenue by Country (2025-2030) & (US$ Million)
Table 125. Europe In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 126. Europe In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 127. Europe In-Vitro Diagnostics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 128. Europe In-Vitro Diagnostics Revenue by Country (2019-2024) & (US$ Million)
Table 129. Europe In-Vitro Diagnostics Revenue by Country (2025-2030) & (US$ Million)
Table 130. China In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 131. China In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 132. Asia In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 133. Asia In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 134. Asia In-Vitro Diagnostics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 135. Asia In-Vitro Diagnostics Revenue by Country (2019-2024) & (US$ Million)
Table 136. Asia In-Vitro Diagnostics Revenue by Country (2025-2030) & (US$ Million)
Table 137. MEALA In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 138. MEALA In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 139. MEALA In-Vitro Diagnostics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 140. MEALA In-Vitro Diagnostics Revenue by Country (2019-2024) & (US$ Million)
Table 141. MEALA In-Vitro Diagnostics Revenue by Country (2025-2030) & (US$ Million)
Table 142. Research Programs/Design for This Report
Table 143. Authors List of This Report
Table 144. Secondary Sources
Table 145. Primary Sources
LIST OF FIGURES
Figure 1. In-Vitro Diagnostics Product Picture
Figure 2. Global In-Vitro Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global In-Vitro Diagnostics Market Size Share 2019 VS 2023 VS 2030
Figure 4. Tissue Diagnostics Picture
Figure 5. Professional Diagnostic Picture
Figure 6. Molecular Diagnostic Picture
Figure 7. Diabetes Monitoring Picture
Figure 8. Other Picture
Figure 9. Global In-Vitro Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 10. Global In-Vitro Diagnostics Market Size Share 2019 VS 2023 VS 2030
Figure 11. Diabetes Picture
Figure 12. Infectious Diseases Picture
Figure 13. Oncology Picture
Figure 14. Cardiology Picture
Figure 15. HIV Picture
Figure 16. Other Picture
Figure 17. Global In-Vitro Diagnostics Market Size (US$ Million) & (2019-2030)
Figure 18. Global In-Vitro Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global In-Vitro Diagnostics Market Share by Region: 2019 VS 2023 VS 2030
Figure 20. Global In-Vitro Diagnostics Players Revenue Share Top 10 and Top 5 in 2023
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 22. Global In-Vitro Diagnostics Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global In-Vitro Diagnostics Revenue Market Share 2019 VS 2023 VS 2030
Figure 24. Global In-Vitro Diagnostics Revenue Market Share by Type (2019-2030)
Figure 25. Global In-Vitro Diagnostics Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 26. Global In-Vitro Diagnostics Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 27. Global In-Vitro Diagnostics Revenue Market Share by Application (2019-2030)
Figure 28. North America In-Vitro Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 29. North America In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 30. North America In-Vitro Diagnostics Revenue Share by Type (2019-2030)
Figure 31. North America In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 32. North America In-Vitro Diagnostics Revenue Share by Application (2019-2030)
Figure 33. North America In-Vitro Diagnostics Revenue Share by Country (2019-2030)
Figure 34. United States In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 35. Canada In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 36. Europe In-Vitro Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 37. Europe In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 38. Europe In-Vitro Diagnostics Revenue Share by Type (2019-2030)
Figure 39. Europe In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 40. Europe In-Vitro Diagnostics Revenue Share by Application (2019-2030)
Figure 41. Europe In-Vitro Diagnostics Revenue Share by Country (2019-2030)
Figure 42. Germany In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. France In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 44. U.K. In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 45. Italy In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 46. Russia In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 47. Nordic Countries In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 48. China In-Vitro Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 49. China In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 50. China In-Vitro Diagnostics Revenue Share by Type (2019-2030)
Figure 51. China In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 52. China In-Vitro Diagnostics Revenue Share by Application (2019-2030)
Figure 53. Asia In-Vitro Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 54. Asia In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 55. Asia In-Vitro Diagnostics Revenue Share by Type (2019-2030)
Figure 56. Asia In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 57. Asia In-Vitro Diagnostics Revenue Share by Application (2019-2030)
Figure 58. Asia In-Vitro Diagnostics Revenue Share by Country (2019-2030)
Figure 59. Japan In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. South Korea In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 61. India In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 62. Australia In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 63. China Taiwan In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 64. Southeast Asia In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 65. MEALA In-Vitro Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 66. MEALA In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 67. MEALA In-Vitro Diagnostics Revenue Share by Type (2019-2030)
Figure 68. MEALA In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 69. MEALA In-Vitro Diagnostics Revenue Share by Application (2019-2030)
Figure 70. MEALA In-Vitro Diagnostics Revenue Share by Country (2019-2030)
Figure 71. Mexico In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. South Korea In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Brazil In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Israel In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. Argentina In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. Colombia In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 77. Turkey In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 78. Saudi Arabia In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 79. UAE In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 80. Years Considered
Figure 81. Research Process
Figure 82. Key Executives Interviewed
Figure 1. In-Vitro Diagnostics Product Picture
Figure 2. Global In-Vitro Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global In-Vitro Diagnostics Market Size Share 2019 VS 2023 VS 2030
Figure 4. Tissue Diagnostics Picture
Figure 5. Professional Diagnostic Picture
Figure 6. Molecular Diagnostic Picture
Figure 7. Diabetes Monitoring Picture
Figure 8. Other Picture
Figure 9. Global In-Vitro Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 10. Global In-Vitro Diagnostics Market Size Share 2019 VS 2023 VS 2030
Figure 11. Diabetes Picture
Figure 12. Infectious Diseases Picture
Figure 13. Oncology Picture
Figure 14. Cardiology Picture
Figure 15. HIV Picture
Figure 16. Other Picture
Figure 17. Global In-Vitro Diagnostics Market Size (US$ Million) & (2019-2030)
Figure 18. Global In-Vitro Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global In-Vitro Diagnostics Market Share by Region: 2019 VS 2023 VS 2030
Figure 20. Global In-Vitro Diagnostics Players Revenue Share Top 10 and Top 5 in 2023
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 22. Global In-Vitro Diagnostics Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global In-Vitro Diagnostics Revenue Market Share 2019 VS 2023 VS 2030
Figure 24. Global In-Vitro Diagnostics Revenue Market Share by Type (2019-2030)
Figure 25. Global In-Vitro Diagnostics Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 26. Global In-Vitro Diagnostics Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 27. Global In-Vitro Diagnostics Revenue Market Share by Application (2019-2030)
Figure 28. North America In-Vitro Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 29. North America In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 30. North America In-Vitro Diagnostics Revenue Share by Type (2019-2030)
Figure 31. North America In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 32. North America In-Vitro Diagnostics Revenue Share by Application (2019-2030)
Figure 33. North America In-Vitro Diagnostics Revenue Share by Country (2019-2030)
Figure 34. United States In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 35. Canada In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 36. Europe In-Vitro Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 37. Europe In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 38. Europe In-Vitro Diagnostics Revenue Share by Type (2019-2030)
Figure 39. Europe In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 40. Europe In-Vitro Diagnostics Revenue Share by Application (2019-2030)
Figure 41. Europe In-Vitro Diagnostics Revenue Share by Country (2019-2030)
Figure 42. Germany In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. France In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 44. U.K. In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 45. Italy In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 46. Russia In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 47. Nordic Countries In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 48. China In-Vitro Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 49. China In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 50. China In-Vitro Diagnostics Revenue Share by Type (2019-2030)
Figure 51. China In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 52. China In-Vitro Diagnostics Revenue Share by Application (2019-2030)
Figure 53. Asia In-Vitro Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 54. Asia In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 55. Asia In-Vitro Diagnostics Revenue Share by Type (2019-2030)
Figure 56. Asia In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 57. Asia In-Vitro Diagnostics Revenue Share by Application (2019-2030)
Figure 58. Asia In-Vitro Diagnostics Revenue Share by Country (2019-2030)
Figure 59. Japan In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. South Korea In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 61. India In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 62. Australia In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 63. China Taiwan In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 64. Southeast Asia In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 65. MEALA In-Vitro Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 66. MEALA In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 67. MEALA In-Vitro Diagnostics Revenue Share by Type (2019-2030)
Figure 68. MEALA In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 69. MEALA In-Vitro Diagnostics Revenue Share by Application (2019-2030)
Figure 70. MEALA In-Vitro Diagnostics Revenue Share by Country (2019-2030)
Figure 71. Mexico In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. South Korea In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Brazil In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Israel In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. Argentina In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. Colombia In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 77. Turkey In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 78. Saudi Arabia In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 79. UAE In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 80. Years Considered
Figure 81. Research Process
Figure 82. Key Executives Interviewed
